Journal
Open Forum Infectious Diseases
Publication Date
3-1-2024
Volume
11
Issue
3
First Page
ofae010
Document Type
Open Access Publication
DOI
10.1093/ofid/ofae010
Rights and Permissions
Andrej Spec, George R Thompson, Marisa H Miceli, Justin Hayes, Laurie Proia, David McKinsey, Ana Belen Arauz, Kathleen Mullane, Jo-Ann Young, Gerald McGwin, Rachel McMullen, Tyler Plumley, Mary K Moore, Lee Ann McDowell, Carolynn Jones, Peter G Pappas, MSG-15: Super-Bioavailability Itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses—A Multicenter, Open-Label, Randomized Comparative Trial, Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae010, https://doi.org/10.1093/ofid/ofae010. https://academic.oup.com/ofid/article/11/3/ofae010/7590982?login=true. © The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Spec, Andrej and et al., "MSG-15: Super-bioavailability itraconazole versus conventional itraconazole in the treatment of endemic mycoses-A multicenter, open-label, randomized comparative trial." Open Forum Infectious Diseases. 11, 3. ofae010 (2024).
https://digitalcommons.wustl.edu/oa_4/3394
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
